Your browser doesn't support javascript.
loading
Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.
Pouget, Jennie G; Han, Buhm; Wu, Yang; Mignot, Emmanuel; Ollila, Hanna M; Barker, Jonathan; Spain, Sarah; Dand, Nick; Trembath, Richard; Martin, Javier; Mayes, Maureen D; Bossini-Castillo, Lara; López-Isac, Elena; Jin, Ying; Santorico, Stephanie A; Spritz, Richard A; Hakonarson, Hakon; Polychronakos, Constantin; Raychaudhuri, Soumya; Knight, Jo.
Afiliação
  • Pouget JG; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.
  • Han B; Department of Psychiatry, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Mignot E; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Ollila HM; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
  • Barker J; Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • Spain S; Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • Dand N; Finnish Institute for Molecular Medicine, Helsinki, Finland.
  • Trembath R; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA and Broad Institute, Cambridge, MA, USA.
  • Martin J; School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Mayes MD; St. John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Bossini-Castillo L; School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • López-Isac E; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Jin Y; School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Santorico SA; School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Spritz RA; Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK.
  • Hakonarson H; Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain.
  • Polychronakos C; The University of Texas Health Science Center-Houston, Houston, USA.
  • Raychaudhuri S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
  • Knight J; Institute of Parasitology and Biomedicine López-Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain.
Hum Mol Genet ; 28(20): 3498-3513, 2019 10 15.
Article em En | MEDLINE | ID: mdl-31211845
Many immune diseases occur at different rates among people with schizophrenia compared to the general population. Here, we evaluated whether this phenomenon might be explained by shared genetic risk factors. We used data from large genome-wide association studies to compare the genetic architecture of schizophrenia to 19 immune diseases. First, we evaluated the association with schizophrenia of 581 variants previously reported to be associated with immune diseases at genome-wide significance. We identified five variants with potentially pleiotropic effects. While colocalization analyses were inconclusive, functional characterization of these variants provided the strongest evidence for a model in which genetic variation at rs1734907 modulates risk of schizophrenia and Crohn's disease via altered methylation and expression of EPHB4-a gene whose protein product guides the migration of neuronal axons in the brain and the migration of lymphocytes towards infected cells in the immune system. Next, we investigated genome-wide sharing of common variants between schizophrenia and immune diseases using cross-trait LD score regression. Of the 11 immune diseases with available genome-wide summary statistics, we observed genetic correlation between six immune diseases and schizophrenia: inflammatory bowel disease (rg = 0.12 ± 0.03, P = 2.49 × 10-4), Crohn's disease (rg = 0.097 ± 0.06, P = 3.27 × 10-3), ulcerative colitis (rg = 0.11 ± 0.04, P = 4.05 × 10-3), primary biliary cirrhosis (rg = 0.13 ± 0.05, P = 3.98 × 10-3), psoriasis (rg = 0.18 ± 0.07, P = 7.78 × 10-3) and systemic lupus erythematosus (rg = 0.13 ± 0.05, P = 3.76 × 10-3). With the exception of ulcerative colitis, the degree and direction of these genetic correlations were consistent with the expected phenotypic correlation based on epidemiological data. Our findings suggest shared genetic risk factors contribute to the epidemiological association of certain immune diseases and schizophrenia.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Predisposição Genética para Doença / Doenças do Sistema Imunitário Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Predisposição Genética para Doença / Doenças do Sistema Imunitário Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá